Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-20-016458

Exec. VP, European Commercial sold 991 shares at $11.77 ($11,660)

  • Exec. VP, European Commercial acquired 2,098 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Daniell Richard · Exec. VP, European Commercial

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-03-03 Exercise or conversion : show line 1 in the form +2,098 10,710 D
2020-03-03 Sale : show line 2 in the form −991 $11.77 $11,660 9,719 D
Open-market sales · 991 sh · avg $11.77 · $11,660

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-03-03 Exercise or conversion : show line 3 in the form Restricted Share Units −2,098 2,101 D
Loading xslF345X03/doc4.xml…